Market Research Logo

Global Inflammatory Bowel Disease Market 2015-2019

About Inflammatory Bowel Disease

Inflammatory bowel disease is a condition includes a group of autoimmune diseases such as Crohn's disease and ulcerative colitis. It causes chronic inflammation of a specific part or the entire GI tract. Both Crohn's disease and ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal cramps and pain, rectal bleeding, fatigue, and weight loss. Inflammatory bowel disease can also prove to be life-threatening for the patients. Ulcerative colitis generally affects the colon, where inflammation and ulcers develop in the innermost lining of the colon and the rectum of a patient. Crohn's disease causes inflammation of the lining of the GI tract. The inflammation in Crohn's disease affects various areas of the GI tract such as the large intestine and small intestine, or both. Inflammatory bowel disease is a chronic medical condition, which has no permanent cure and demands a lifetime of treatment and management. The preferred treatment options include anti-inflammatory steroidal products and immuno-suppressive agents such as the TNF-α inhibitors.

TechNavio's analysts forecast the Global Inflammatory Bowel Disease market to grow at a CAGR of 3.95 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Inflammatory Bowel Disease market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of inflammatory bowel disease. The market includes data from the sales of various drusg which are used for the treatment of Crohn's Disease and Ulcerative Colitis.
On the basis of the functioning of the drugs used for treatment, the Global Inflammatory Bowel Disease market is categorized into three segments.

  • 5-ASA
  • Antibiotics
  • Immunomodulators
  • On the basis of the type of molecule used for treatment, the Global Inflammatory Bowel Disease market is categorized into two segments.
  • Biologics
  • Small Molecules
  • On the basis of route of administration adopted for the treatment, the Global Inflammatory Bowel Disease market is categorized into two segments.
  • Oral
  • Parenteral
  • On the basis of the form of drug used to treat the disease, the Global Inflammatory Bowel Disease market is categorized into two segments.
  • Solid
  • Liquid
  • The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Inflammatory Bowel Disease market. The vendor landscape includes an analysis of the major vendors, along with the competitive performances of their portfolios. In addition, the report discusses the major drivers, challenges and trends influencing the market. In addition, late-stage pipeline molecules developed for the treatment of inflammatory bowel disease are discussed.

    TechNavio's report, Global Inflammatory Bowel Disease Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the landscape of the Global Inflammatory Bowel Disease market and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key Regions
    • Americas
    • APAC
    • EMEA
    Key Vendors
    • Abbvie
    • Biogen Idec
    • Janssen Pharmaceuticals
    • Merck & Company
    • Shire
    • UCB
    Other Prominent Vendors
    • Amgen
    • Akebia Therapeutics
    • Boehringer Ingelheim
    • Celltrion
    • ChemoCentryx
    • Ferring Pharmaceuticals
    • Galapagos
    • Genentech
    • Merck
    • Mitsubishi Tanabe
    • Novartis
    • Novo Nordisk
    • Pfizer
    • Salix Pharmaceuticals
    Market Driver
    • Increase in Instances of Inflammatory Bowel Disease
    • For a full, detailed list, view our report
    Market Challenge
    • High Cost of Drugs
    • For a full, detailed list, view our report
    Market Trend
    • Dominance of Market by Biologics
    • For a full, detailed list, view our report
    Key Questions Answered in this Report
    • What will the market size be in 2019 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?


    Press Release

    Technavio Announces the Publication of its Research Report – Global Inflammatory Bowel Disease Market 2015-2019

    Technavio recognizes the following companies as the key players in the Global Inflammatory Bowel Disease Market 2015-2019: AbbVie Inc., Biogen Idec Inc., Janssen Pharmaceuticals Inc., Merck & Co. Inc., Shire plc and UCB SA.

    Other Prominent Vendors in the market are: Amgen, Akebia Therapeutics, Boehringer Ingelheim, Celltrion, ChemoCentryx, Ferring Pharmaceuticals, Galapagos, Genentech, Mitsubishi Tanabe, Novartis, Novo Nordisk, Pfizer and Salix Pharmaceuticals.

    Commenting on the report, an analyst from Technavio’s team said: “The dominance of the market by biologics used to treat patients suffering from the disease is one of the emerging trends. Biologics are expected to become a preferred treatment option for the medical fraternity, patients, and the families of patients during the forecast period. This leads to a rise in the number of treatment-seeking patients, which increases the overall consumption of medicines.”

    According to the report, the high prevalence of inflammatory bowel disease among the population resulting in a rise in the number of treatment-seeking patients has led to increased consumption of medications, thereby having a positive impact on the market share of the vendors.

    Further, the report states the high cost of drugs used to treat patients suffering from inflammatory bowel disease is one of the major challenges hindering the growth of the market.

    Companies Mentioned

    AbbVie Inc., Biogen Idec Inc., Janssen Pharmaceuticals Inc., Merck & Co. Inc., Shire plc and UCB SA., Amgen, Akebia Therapeutics, Boehringer Ingelheim, Celltrion, ChemoCentryx, Ferring Pharmaceuticals, Galapagos, Genentech, Mitsubishi Tanabe, Novartis, Novo Nordisk, Pfizer and Salix Pharmaceuticals

    • Executive Summary
    • List of Abbreviations
    • Scope of the Report
      • Market overview
      • Product offerings
    • Market Research Methodology
      • Market research process
      • Research methodology
        • Table Market research methodology
    • Introduction
      • Table Challenges and drivers of global inflammatory bowel disease market
    • Disease Overview: Crohn's Disease
      • Understanding the disease
        • Table Overview of Crohn's disease
        • Table Classification of Crohn's disease
      • Etiology
        • Autoimmune reaction
        • Genes
        • Environment
      • Stages of Crohn's disease
      • Epidemiology
        • Worldwide prevalence of Crohn's disease
          • Table Expected number of global Crohn's disease cases 2015-2022
          • Table Global variation in incidence rates for Crohn's disease in 2012 (in %)
        • US
          • Table Prevalence of Crohn's disease in US
          • Table Incidence of Crohn's disease in US
        • UK
      • Symptoms
        • Table Symptoms of Crohn's disease
        • Diarrhea
        • Fever and fatigue
        • Abdominal pain and cramping
        • Perianal disease and blood in stool
        • Reduced appetite and weight loss
      • Diagnosis and testing
        • Table Crohn's disease: diagnosis and testing
        • Early tests and exams
        • Endoscopy and biopsy
        • Chromoendoscopy
        • Small intestinal imaging
      • Treatment
        • Table Crohn's disease: treatment
        • Medication
          • Table Treatment landscape for Crohn's disease
        • Diet and nutrition
        • Surgery
          • Table Crohn's disease: treatment pathway
    • Disease Overview: Ulcerative Colitis
      • Understanding the disease
      • Etiology
        • Autoimmune reaction
        • Genetics
        • Environmental factors
      • Prognosis
      • Epidemiology
        • Global
        • UK
        • US
      • Symptoms
        • Table Ulcerative colitis: Symptoms
      • Diagnosis and testing
        • Table Diagnostic approach for ulcerative colitis
      • Treatment
        • Medical treatment options
          • Table Treatment options for ulcerative colitis
        • Surgical procedures
          • Table Surgical procedures to treat ulcerative colitis
    • Pipeline Portfolio
      • Crohn's disease pipeline landscape
        • Table Crohn's disease: pipeline portfolio
        • Some emerging therapeutic options
          • Table Crohn's disease clinical trial by phase
          • Table Crohn's disease clinical trial by status
      • Ulcerative colitis pipeline landscape
        • Table Ulcerative colitis: pipeline portfolio
    • Market Landscape
      • Global inflammatory bowel disease market
        • Table Snapshot of global inflammatory bowel disease market 2014
      • Market size and forecast
        • Table Global inflammatory bowel disease market 2014-2019 ($ million)
      • Inflammatory bowel disease market in US
        • Market size and forecast
          • Table Inflammatory bowel disease market in US 2014-2019 ($ million)
      • Inflammatory bowel disease market in EU
        • Market size and forecast
          • Table Inflammatory bowel disease market in EU 2014-2019 ($ million)
      • Inflammatory bowel disease market in Japan
        • Market size and forecast
          • Table Inflammatory bowel disease market in Japan 2014-2019 ($ million)
      • Five forces analysis
    • Market Segmentation by Type of Disease
      • Table Segmentation of global inflammatory bowel disease market by type of disease
      • Crohn's disease
      • Ulcerative colitis
        • Table Segmentation of global inflammatory bowel disease market by type of disease 2014
        • Table Segmentation of global inflammatory bowel disease market by type of disease 2019
        • Table Revenue of global inflammatory bowel disease market 2014-2019 ($ million)
    • Global Crohn's Disease Market
      • Table Snapshot of global Crohn's disease market 2014
      • Market size and forecast
        • Table Global Crohn's disease market 2014-2019 ($ million)
      • Crohn's disease market in US
        • Market size and forecast
          • Table Crohn's disease market in US 2014-2019 ($ million)
      • Crohn's disease market in Japan
        • Market size and forecast
          • Table Crohn's disease market in Japan 2014-2019 ($ million)
    • Global Ulcerative Colitis Market
      • Table Snapshot of global ulcerative colitis market
      • Market size and forecast
        • Table Global ulcerative colitis market 2014-2019 ($ million)
    • Market Segmentation by Drug Class
      • Table Segmentation of global inflammatory bowel disease market by drug class
      • Table Benefits and risks of 5-ASA
      • Table Segmentation of global inflammatory bowel disease market by drug class 2014
    • Market Segmentation by Type of Molecule
      • Table Segmentation of global inflammatory bowel disease market by type of molecule
      • Biologics
      • Small molecules
        • Table Segmentation of global inflammatory bowel disease market by type of molecule 2014
    • Market Segmentation by Dosage Form
      • Table Segmentation of global inflammatory bowel disease market by dosage form
      • Solid
      • Liquid
        • Table Segmentation of global inflammatory bowel disease market by dosage form 2014
    • Market Segmentation by Route of Administration
      • Table Segmentation of global inflammatory bowel disease market by route of administration
      • Oral
      • Parenteral
        • Table Segmentation of global inflammatory bowel disease market by route of administration 2014
    • Geographical Segmentation
      • Segmentation of global inflammatory market by geography
        • Table Segmentation of global inflammatory bowel disease market by geography 2014
        • Table Segmentation of global inflammatory bowel disease market by geography 2019
      • Segmentation of global Crohn's disease and ulcerative colitis markets by geography
      • Segmentation of global Crohn's disease market by geography
        • Table Segmentation of global Crohn's disease market by geography 2014
      • Segmentation of global ulcerative colitis market by geography
        • Table Segmentation of global ulcerative colitis market by geography 2014
    • Key Leading Countries
      • Key leading countries 2014
      • Key leading countries 2019
      • US
      • Japan
    • Buying Criteria
    • Market Growth Drivers
      • Table Major drivers of global inflammatory bowel disease market
    • Drivers and their Impact
    • Market Challenges
      • Table Major challenges in global inflammatory bowel disease market
    • Impact of Drivers and Challenges
    • Market Trends
      • Table Major trends in global inflammatory bowel disease market
    • Trends and their Impact
    • Vendor Landscape
      • Competitive scenario
        • Key news
        • Mergers and acquisitions
      • Market share analysis 2014
        • Table Ranking of vendors 2014
        • Competitive assessment of top drugs for inflammatory bowel disease
          • Table YoY revenue of top drugs for inflammatory bowel disease 2010-2014 ($ million)
          • Table Revenue share of top drugs for inflammatory bowel disease 2010-2014
        • AbbVie
          • Table AbbVie: product portfolio
          • Table YoY global revenue of Humira 2009-2014 ($ million)
          • Table YoY revenue of Humira in US 2009-2014 ($ million)
          • Table YoY international revenue of Humira (except US) 2009-2014 ($ million)
          • Table Revenue comparison of Humira 2009-2014 ($ million)
        • Janssen Pharmaceuticals
          • Table Janssen: product portfolio
          • Table YoY global revenue of Remicade 2009-2014 ($ million)
          • Table YoY global revenue of Simponi 2010-2014 ($ million)
        • Merck
          • Table Merck: product portfolio
          • Table YoY global revenue of Remicade 2009-2014 ($ million)
          • Table YoY global revenue of Simponi 2010-2014 ($ million)
        • Biogen Idec
          • Table Biogen Idec: product portfolio
          • Table YoY global revenue of Tysabri 2009-2014 ($ million)
          • Table YoY revenue of Tysabri in US 2009-2014 ($ million)
          • Table YoY revenue of Tysabri in ROW 2009-2014 ($ million)
          • Table Global revenue of Tysabri 2009-2014 ($ million)
        • UCB
          • Table UCB: product portfolio
          • Table YoY global revenue of Cimzia 2010-2014 ($ million)
        • Shire
          • Table Shire: product portfolio
          • Table YoY global revenue of Lialda 2010-2014 ($ million)
      • Other and future prominent vendors
    • Key Vendor Analysis
      • AbbVie
        • Key facts
        • Business overview
        • Product segmentation by revenue 2013
          • Table AbbVie: product segmentation by revenue 2013
        • Product segmentation by revenue 2012 and 2013
          • Table AbbVie: product segmentation by revenue 2012 and 2013 ($ million)
        • Sales by geography
          • Table AbbVie: sales by geography 2013
        • Business strategy
        • Key developments
        • SWOT analysis
      • Biogen Idec
        • Key facts
        • Business overview
        • Business segmentation by revenue 2013
          • Table Biogen Idec: business segmentation by revenue 2013
        • Geographical segmentation by revenue 2013
          • Table Biogen Idec: geographical segmentation by revenue 2013
        • Business strategy
        • Key developments
        • SWOT analysis
      • Janssen Pharmaceuticals
        • Key facts
        • Business overview
        • Recent developments
        • SWOT analysis
      • Merck
        • Key facts
        • Business overview
        • Business segmentation by revenue 2013
          • Table Merck: business segmentation by revenue 2013
        • Business segmentation by revenue 2012 and 2013
          • Table Merck: business segmentation by revenue 2012 and 2013 ($ billion)
        • Sales by geography
          • Table Merck: sales by geography 2013
        • Business strategy
        • Key developments
        • SWOT analysis
      • Shire
        • Key facts
        • Business overview
        • Geographical segmentation by revenue 2013
          • Table Shire: geographical segmentation by revenue 2013
        • Business strategy
        • Recent developments
        • SWOT analysis
      • UCB
        • Key facts
        • Business overview
        • Product segmentation by revenue 2013
          • Table UCB: product segmentation by revenue 2013
        • Product segmentation by revenue 2012 and 2013
          • Table UCB: product segmentation by revenue 2012 and 2013 ($ million)
        • Geographical segmentation by revenue 2013
          • Table UCB: geographical segmentation by revenue 2013
        • Business strategy
        • Recent developments
        • SWOT analysis
    • Other Reports in this Series

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report